Comment

Comment by Dr. Krishna Kumari Challa on December 17, 2021 at 10:07am

World's first optical oscilloscope

 A team from UCF has developed the world's first optical oscilloscope, an instrument that is able to measure the electric field of light. The device converts light oscillations into electrical signals, much like hospital monitors convert a patient's heartbeat into electrical oscillation.

Until now, reading the electric field of light has been a challenge because of the high speeds at which light waves oscillates. The most advanced techniques, which power our phone and internet communications, can currently clock electric fields at up to gigahertz frequencies—covering the radio frequency and microwave regions of the electromagnetic spectrum. Light waves oscillate at much higher rates, allowing a higher density of information to be transmitted. However, the current tools for measuring light fields could resolve only an average signal associated with a 'pulse' of light, and not the peaks and valleys within the pulse. Measuring those peaks and valleys within a single pulse is important because it is in that space that information can be packed and delivered.

Fiber optic communications have taken advantage of light to make things faster, but we are still functionally limited by the speed of the oscilloscope. This new  optical oscilloscope may be able to increase that speed by a factor of about 10,000.

The research team developed the device and demonstrated its capability for real-time measurement of the electric fields of individual laser pulses. The next step for the team is to see how far they can push the speed limits of the technique.

https://www.ucf.edu/news/ucf-develops-the-worlds-first-optical-osci...

https://researchnews.cc/news/10569/Team-develops-the-world-s-first-...

Comment by Dr. Krishna Kumari Challa on December 16, 2021 at 8:20am

How NASA’s Webb Telescope Will Transform Our Place in the Universe

Comment by Dr. Krishna Kumari Challa on December 16, 2021 at 8:14am

Sodium-based material yields stable alternative to lithium-ion batteries

Researchers have created a new sodium-based battery material that is highly stable, capable of recharging as quickly as a traditional lithium-ion battery and able to pave the way toward delivering more energy than current battery technologies.

For about a decade, scientists and engineers have been developing sodium batteries, which replace both lithium and cobalt used in current lithium-ion batteries with cheaper, more environmentally friendly sodium. Unfortunately, in earlier sodium batteries, a component called the anode would tend to grow needle-like filaments called dendrites that can cause the battery to electrically short and even catch fire or explode.

Typically, the faster you charge, the more of these dendrites you grow. So if you suppress dendrite growth, you can charge and discharge faster, because all of a sudden it's safe.

 Yixian Wang et al, A Sodium–Antimony–Telluride Intermetallic Allows Sodium‐Metal Cycling at 100% Depth of Discharge and as an Anode‐Free Metal Battery, Advanced Materials (2021). DOI: 10.1002/adma.202106005

In one of two recent sodium battery advances from UT Austin, the new material solves the dendrite problem and recharges as quickly as a lithium-ion battery. The team published their results in the journal Advanced Materials.

https://techxplore.com/news/2021-12-sodium-based-material-yields-st...

**

Comment by Dr. Krishna Kumari Challa on December 16, 2021 at 7:56am

Using AI to Navigate Flow

Comment by Dr. Krishna Kumari Challa on December 14, 2021 at 11:47am

A longer-lasting COVID vaccine

Researchers have identified rare, naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other coronaviruses.

The findings suggest that a component of this protein, called viral polymerase, could potentially be added to COVID-19 vaccines to create a longer-lasting immune response and increase protection against new variants of the virus.

Most COVID-19 vaccines use part of the spike protein found on the surface of the virus to prompt the immune system to produce antibodies. However, newer variants — such as delta and omicron — carry mutations to the spike protein, which can make them less recognizable to the immune cells and antibodies stimulated by vaccination. Researchers say that a new generation of vaccines will likely be needed to create a more robust and wide-ranging immune response capable of beating back current variants and those that may arise in the future.

One way to accomplish this is by adding a fragment of a different viral protein to vaccines — one that is less prone to mutations than the spike protein and that will activate the immune system’s T cells. T cells are equipped with molecular receptors on their surfaces that recognize foreign protein fragments called antigens. When a T cell encounters an antigen its receptor recognizes, it self-replicates and produces additional immune cells, some of which target and kill infected cells immediately and others which remain in the body for decades to fight that same infection should it ever return.

The researchers focused on the viral polymerase protein, which is found not only in SARS-CoV-2 but in other coronaviruses, including those that cause SARS, MERS and the common cold. Viral polymerases serve as engines that coronaviruses use to make copies of themselves, enabling infection to spread. Unlike the spike protein, viral polymerases are unlikely to change or mutate, even as viruses evolve.

To determine whether or not the human immune system has T cell receptors capable of recognizing viral polymerase, the researchers exposed blood samples from healthy human donors (collected prior to the COVID-19 pandemic) to the viral polymerase antigen. They found that certain T cell receptors did, in fact, recognize the polymerase. They then used a method they developed called CLInt-Seq to genetically sequence these receptors. Next, the researchers engineered T cells to carry these polymerase-targeting receptors, which enabled them to study the receptors’ ability to recognize and kill SARS-CoV-2 and other coronaviruses.

The study was published online in the journal Cell Reports.

https://researchnews.cc/news/10477/A-longer-lasting-COVID-vaccine--...

---

**

Comment by Dr. Krishna Kumari Challa on December 14, 2021 at 10:48am

Testing Mars Sample Return

Teams across multiple NASA centers and the European Space Agency are working together to prepare a set of missions that would return the samples being collected by the Mars Perseverance rover safely back to Earth. This video features some of that prototype testing underway for the proposed Sample Retrieval Lander, Mars Ascent Vehicle launch systems, and the Earth Entry System. Credit: NASA/JPL-Caltech

Comment by Dr. Krishna Kumari Challa on December 14, 2021 at 10:17am

New resistance-busting antibiotic combination could extend the use of 'last-resort' antibiotics

Scientists have discovered a new potential treatment that has the ability to reverse antibiotic resistance in bacteria that cause conditions such as sepsis, pneumonia, and urinary tract infections.

Carbapenems, such as meropenem, are a group of vital often 'last-resort' antibiotics used to treat serious, multi-drug resistant infections when other antibiotics, such as penicillin, have failed. But some bacteria have found a way to survive treatment with carbapenems, by producing enzymes called metallo-beta-lactamases (MBLs) that break down the carbapenem antibiotics, stopping them from working.

Highly collaborative research, conducted by scientists from the Ineos Oxford Institute (IOI) for Antimicrobial Research at the University of Oxford and several institutions across Europe, found that the new class of enzyme blockers, called indole carboxylates, can stop MBL resistance enzymes working leaving the antibiotic free to attack and kill bacteria such as E. coli in the lab and in infections in mice.

The researchers first screened hundreds of thousands of chemicals to see which would attach tightly to MBLs to stop them working, and which didn't react with any human proteins, leading to the discovery of the indole carboxylates as promising new candidates. Using a process called crystallography to zoom in to take a closer look at how they work, the researchers found these potential drugs attach to MBLs in a completely different way to any other drugs—they imitate the interaction of the antibiotic with the MBLs. This clever Trojan Horse trick allows these potential drugs to be highly effective against a very wide range of MBL-producing superbugs.

Jürgen Brem, Imitation of β-lactam binding enables -spectrum metallo-β-lactamase inhibitors, Nature Chemistry (2021). DOI: 10.1038/s41557-021-00831-x. www.nature.com/articles/s41557-021-00831-x

https://phys.org/news/2021-12-resistance-busting-antibiotic-combina...

Comment by Dr. Krishna Kumari Challa on December 14, 2021 at 10:12am

Researchers discover how cells from tumors remain dormant for years before metastasis occurs

Researchers have solved a major mystery in cancer research: How cancer cells remain dormant for years after they leave a tumor and travel to other parts of the body, before awakening to create metastatic cancer.

According to findings reported in Nature Cancer in December, the cells remain quiet by secreting a type of collagen, called type III collagen, in the environment around themselves, and only turn malignant once the level of collagen tapers off. The researchers found that by enriching the environment around the cells with this collagen, they could force the cells to remain in a dormant state and prevent tumour recurrence.

Most cancer deaths are due to metastases, which can occur several years after a tumor is removed. Previous research has studied how dispersed tumor cells come out of dormancy; this new work showed how the cells remain dormant.

In patient samples, the researchers showed that an abundance of the collagen could be used as a potential measurement to predict tumor recurrence and metastasis. In the mouse models, when scientists increased the amount of type III collagen around cancer cells that had left a tumor, cancer progression was interrupted and the disseminated cells were forced into a dormant state. Similar to wound treatment, in which collagen scaffolds have been proposed as a therapeutic alternative for complex skin wounds, this study suggest that by using strategies that aim to enrich the tumor microenvironment in type III collagen, metastasis may be prevented by activating tumor cell dormancy.

Jose Bravo-Cordero, A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy, Nature Cancer (2021). DOI: 10.1038/s43018-021-00291-9. www.nature.com/articles/s43018-021-00291-9

https://medicalxpress.com/news/2021-12-cells-tumors-dormant-years-m...

Comment by Dr. Krishna Kumari Challa on December 14, 2021 at 8:47am

Synthetic food dyes and cancer

Although none of the FDA-approved synthetic food colors are classified as carcinogens, currently available research points to potential health risks and   researchers  find this concerning.

For instance, the bacteria in your gut can break down synthetic dyes into molecules that are known to cause cancer. More research is needed on how the microbiome interacts with synthetic food coloring and potential cancer risk.

Studies have shown that artificial food dyes can bind to the DNA and proteins inside cells. There is also some evidence that synthetic dyes can stimulate the body's inflammatory machinery. Both of these mechanisms may pose a problem for colon and rectal health.

Synthetic food dyes have been found to damage DNA in rodents. This is supported by unpublished data from my research team showing that Allura Red, or Red 40, and Tartrazine, or Yellow 5, can cause DNA damage in colon cancer cells with increased dosages and length of exposure in vitro in a controlled lab environment.

Our results will need to be replicated in animal and human models before we can say that these dyes directly caused DNA damage, however.

Finally, artificial food coloring may be of particular concern for children. It's known that children are more vulnerable to environmental toxins because their bodies are still developing. I and others believe that this concern may extend to synthetic food dyes, especially considering their prevalence in children's food.

A 2016 study found that over 40 percent of food products marketed toward children in one major supermarket in North Carolina contained artificial food coloring. More research needs to be done to examine how repeated exposure to artificial food dyes may affect children.

A few treats during the holidays won't cause colorectal cancer. But a long-term diet of processed foods might. While more research is needed on the link between synthetic food dyes and cancer, there are evidence-based steps you can take now to reduce your risk of colorectal cancer.

One way is to get screened for colon cancer. Another is to increase your physical activity. Finally, you can eat a healthy diet with more whole grains and produce and less alcohol and red and processed meat. Though this means eating fewer of the colorful, ultra-processed foods that may be plentiful during the holidays, your gut will thank you in the long run.

https://theconversation.com/colorful-sweets-may-look-tasty-but-some...

Comment by Dr. Krishna Kumari Challa on December 14, 2021 at 8:44am

The food industry uses synthetic dyes because they make food look better. The first food dyes were created from coal tar in the late 1800s. Today, they are often synthesized from a chemical derived from petroleum called naphthalene to make a final product called an azo dye.

Food manufacturers prefer synthetic dyes over natural dyes like beet extract because they are cheaper, brighter, and last longer. While manufacturers have developed hundreds of synthetic food dyes over the past century, the majority of them are toxic. Only nine are approved for use in food under U.S. Food and Drug Administration policy, and even fewer pass European Union regulations.

What drives colorectal cancer?

DNA damage is the primary driver of colorectal cancer. When DNA damage occurs on cancer driver genes, it can result in a mutation that tells the cell to divide uncontrollably and turn cancerous.

Another driver of colorectal cancer is inflammation. Inflammation occurs when the immune system sends out inflammatory cells to begin healing an injury or capture disease-causing pathogens.

When this inflammation persists over time, it can harm otherwise healthy cells by releasing molecules called free radicals that can damage DNA.

Another type of molecule called cytokines can prolong inflammation and drive increased cell division and cancer development in the gut when there isn't an injury to heal.

Long-term poor dietary habits can lead to a simmering low-grade inflammation that doesn't produce noticeable symptoms, even while inflammatory molecules continue to damage otherwise healthy cells.

Part 2

• ‹ Previous
• 1
• …
• 312
• 313
• 314
• 315
• 316
• …
• 852
• Next ›
• Page